Cargando…
Associations between expression of indoleamine 2, 3-dioxygenase enzyme and inflammatory cytokines in patients with first-episode drug-naive Schizophrenia
The indoleamine 2,3-dioxygenase (IDO) enzyme is the first rate-limiting enzyme of the tryptophan degradation pathway in which dysfunction of neuroactive metabolites has been implicated in the pathophysiology of schizophrenia. Inflammatory molecules such as pro-inflammatory cytokines could enhance th...
Autores principales: | Zhang, Yan, Shi, Han, Yang, Ge, Yang, Yongfeng, Li, Wenqiang, Song, Meng, Shao, Minglong, Su, Xi, Lv, Luxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606005/ https://www.ncbi.nlm.nih.gov/pubmed/34802039 http://dx.doi.org/10.1038/s41398-021-01688-x |
Ejemplares similares
-
Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022) -
Abnormal patterns of regional homogeneity and functional connectivity across the adolescent first-episode, adult first-episode and adult chronic schizophrenia
por: Yang, Yongfeng, et al.
Publicado: (2022) -
Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017) -
Cortical anatomical variations, gene expression profiles, and clinical phenotypes in patients with schizophrenia
por: Han, Yong, et al.
Publicado: (2023) -
Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
por: Peng, Xuerun, et al.
Publicado: (2022)